.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
Julphar
Covington
Chinese Patent Office
US Department of Justice
Teva
Deloitte
Express Scripts
Cantor Fitzgerald

Generated: November 21, 2017

DrugPatentWatch Database Preview

Alvogen Malta Company Profile

« Back to Dashboard

What is the competitive landscape for ALVOGEN MALTA, and what generic and branded alternatives to ALVOGEN MALTA drugs are available?

ALVOGEN MALTA has twenty-seven approved drugs.



Summary for Alvogen Malta

US Patents:0
Tradenames:25
Ingredients:22
NDAs:27
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990ABRXYesNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
TABLET;ORAL207388-003Jul 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
TENORETIC 100
atenolol; chlorthalidone
TABLET;ORAL018760-001Jun 8, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Alvogen Malta
OXYCODONE AND ACETAMINOPHEN
acetaminophen; oxycodone hydrochloride
TABLET;ORAL202677-003Mar 8, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
FELBAMATE
felbamate
TABLET;ORAL204595-002Jan 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
ZESTRIL
lisinopril
TABLET;ORAL019777-006Jan 20, 1999ABRXYesNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
FELBAMATE
felbamate
TABLET;ORAL204595-001Jan 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
ATENOLOL
atenolol
TABLET;ORAL072304-001Jul 15, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
CARBIDOPA
carbidopa
TABLET;ORAL204291-001Jan 8, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
ATENOLOL AND CHLORTHALIDONE
atenolol; chlorthalidone
TABLET;ORAL072301-001May 31, 1990ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alvogen Malta

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
TENORETIC 100
atenolol; chlorthalidone
TABLET;ORAL018760-001Jun 8, 1984► Subscribe► Subscribe
Alvogen Malta
NAPRELAN
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL020353-003Jan 5, 1996► Subscribe► Subscribe
Alvogen Malta
NAPRELAN
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL020353-002Jan 5, 1996► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990► Subscribe► Subscribe
Alvogen Malta
ZESTRIL
lisinopril
TABLET;ORAL019777-003May 19, 1988► Subscribe► Subscribe
Alvogen Malta
MACROBID
nitrofurantoin; nitrofurantoin, macrocrystalline
CAPSULE;ORAL020064-001Dec 24, 1991► Subscribe► Subscribe
Alvogen Malta
ZESTORETIC
hydrochlorothiazide; lisinopril
TABLET;ORAL019888-001Sep 20, 1990► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORETIC 50
atenolol; chlorthalidone
TABLET;ORAL018760-002Jun 8, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
McKesson
Accenture
Teva
Cipla
Farmers Insurance
Julphar
US Army
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot